Literature DB >> 31853748

Comment on: "Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection Under Different Treatment Policies in Malaysia, 2018-2040".

Muhammad Radzi Abu Hassan1, Huan-Keat Chan2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31853748     DOI： 10.1007/s40258-019-00543-x

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN： 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  3 in total

1.  Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders.

Authors:  Huan-Keat Chan; Mohamed Azmi Hassali; Noor Syahireen Mohammed; Azlina Azlan; Muhammad Radzi Abu Hassan
Journal:  BMC Public Health       Date:  2022-02-21       Impact factor: 3.295

2.  Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study.

Authors:  Jessica Markby; Sonjelle Shilton; Xiaohui Sem; Huan Keat Chan; Rosaida Md Said; Sasikala Siva; Zalwani Zainuddin; Norasiah Abu Bakar; Haniza Omar; Ryan Jose Iii Ruiz; Mary Gaeddert; Alexander Tyshkovskiy; Madeline Adee; Jagpreet Chhatwal; Suresh Kumar; Jean-Michel Piedagnel; Rozainanee Mohd Zain; Caroline Menétrey; Fazidah Yuswan; Nazrila Hairizan Nasir; Isabelle Andrieux-Meyer; Fatanah Ismail; Rozita Zakaria; Ruziaton Hasim; Shahnaz Murad; Philippa Easterbrook; Muhammad Radzi Abu Hassan
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

Review 3.  TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.

Authors:  Shiri Mermelstein; Hilde Stevens
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.525
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.